Skin minimalism is the new trend in skincare routine. It involves using fewer products that contain active ingredients scientifically proven to be beneficial to the skin. This approach offers protection against harmful substances that cause redness, dryness, and rashes, and improves the absorption of active ingredients.
SPF, vitamin C and E, polypeptides, hyaluronic acid, and ceramides are some of the ingredients that prevent, treat, and repair the skin barrier. Using too many products can damage the skin barrier, disrupt its pH balance, or acid mantle. The goal is to simplify the skincare routine while achieving healthy, glowing skin.
Consulting a board-certified dermatologist is always a good idea to determine the best approach for your specific skin type and concerns. Adopting skin minimalism may help reduce exposure to potential irritants, better absorption of products, and a reduced risk of over-exfoliation.
Skin cycling is another skincare trend that is gaining popularity. This practice involves rotating skincare products to prevent them from irritating our skin or negating each other’s effectiveness due to their chemical formulations.
It is essential to remember that every individual’s skin is unique, and what works for one person may not work for another. Consulting a board-certified dermatologist is always a good idea to determine the best approach for your specific skin type and concerns.
Skin minimalism is centered on three main tenets: cleanse, prevent or treat, and protect the skin. Adopting this philosophy may help reduce exposure to potential irritants, better absorption of products, and a reduced risk of over-exfoliation.
Vertex Pharmaceuticals' VX-880 program offers a radical new way of treating type 1 diabetes, which consists of an infusion of lab-grown, insulin-producing cells made from stem cells. The newest results from a small clinical trial include two patients with over a year of follow-up, each of whom has shown significant drops in their A1C blood sugar levels and no severe hypoglycemic events.
The program infuses lab-made, insulin-producing cells coupled with immunosuppressants to prevent the body from attacking them. The study aims to enroll 17 volunteers in total.
Despite that limitation on VX-880, Vertex hopes to replicate its cystic fibrosis playbook in type 1 by developing a range of medicines to address more and more patients over time.
There are more than a million people with type 1 diabetes in the US, and people with the disease are typically dependent on insulin treatments for life. The potential for a durable treatment, or even a cure, has made Vertex’s program one of the most closely followed in all of diabetes.
Vertex’s other cell therapy programs aim to work without immunosuppressants. One therapy, called VX-264, includes the same cells as VX-880 along with an immune-cloaking device. Even earlier in development, Vertex is investigating ways to genetically edit cells to hide them from the immune system.
The success of Vertex's program has drawn more industry eyes to the cell therapy idea. Despite increasing competition, Vertex is confident in its ability to stay ahead.
There are more than a million people with type 1 diabetes in the US, and people with the disease are typically dependent on insulin treatments for life. The potential for a durable treatment, or even a cure, has made Vertex’s program one of the most closely followed in all of diabetes.
Vertex Pharmaceuticals' VX-880 program offers hope for a cure for type 1 diabetes, a disease that affects more than a million people in the US. The program consists of an infusion of lab-grown, insulin-producing cells made from stem cells, and the newest results from a small clinical trial show significant drops in patients' A1C blood sugar levels.
The promise of a durable treatment or even a cure for type 1 diabetes seems like something out of a fairytale, but with continued research and development in stem cell therapy, it may become a reality. The success of Vertex's program has drawn more industry eyes to the cell therapy idea.
While we may not be able to rely on magic or fairy tales to cure type 1 diabetes, the future looks promising with the ongoing research and development in the field of cell therapy.
Vertex Pharmaceuticals' VX-880 program offers hope for a cure for type 1 diabetes, a disease that affects more than a million people in the US. The program consists of an infusion of lab-grown, insulin-producing cells made from stem cells, and the newest results from a small clinical trial show significant drops in patients' A1C blood sugar levels.
In addition to the exciting news on VX-880, adopting skin minimalism may help reduce exposure to potential irritants, better absorption of products, and a reduced risk of over-exfoliation. Consulting a board-certified dermatologist is always a good idea to determine the best approach for your specific skin type and concerns.
The future looks promising with the ongoing research and development in the field of cell therapy and skincare routine. While we may not be able to rely on magic or fairy tales to cure type 1 diabetes, we can rely on the dedication and hard work of researchers and dermatologists to improve our health and well-being.
We use cookies to store your preferences and analyze how StoryPRO is used.
Your settings can be changed, including withdrawing your consent, at any time on our privacy policy page.
You agree to our use of strictly necessary cookies if you continue to use this website.
Content Restricted To Members
About Author